Last reviewed · How we verify
Dexmedetomidine Analgesic regimen
At a glance
| Generic name | Dexmedetomidine Analgesic regimen |
|---|---|
| Also known as | Epidural Dexmedetomidine Bupivacaine |
| Sponsor | Ain Shams University |
| Modality | Small molecule |
| Phase | FDA-approved |
Approved indications
Common side effects
Key clinical trials
- Opioid Free and Opioid Based Anesthesia in Elective Lumbar Spine Surgery
- Effect of Tegileridine on Postoperative Bowel Function Recovery in Abdominal Surgery (PHASE4)
- COMPARISON OF OPIOID-FREE AND OPIOID-BASED ANESTHESIA TECHNIQUES ON qNOX INDEX IN ABDOMINAL SURGERY UNDER GENERAL ANESTHESIA (NA)
- Dexamethasone Versus Dexmedetomidine in IPACK Block to Reduce Pain Post Arthroscopic Knee Surgeries (PHASE1, PHASE2)
- The Effect of Opioid-Free Anesthesia in TMJ Surgery (PHASE2)
- Effect of Opioid Free Anesthetic on Post-Operative Opioid Consumption After Laparoscopic Bariatric Surgery (PHASE3)
- Evaluation of the Stress Response in Bariatric Surgery With and Without the Use of Opioids (NA)
- Comparative Study Between Two Adjuvant Drugs to Bupivacaine for Post-operative Epidural Analgesia in Abdominal Surgeries (PHASE4)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Dexmedetomidine Analgesic regimen CI brief — competitive landscape report
- Dexmedetomidine Analgesic regimen updates RSS · CI watch RSS
- Ain Shams University portfolio CI